Quote | Super Quote
IPO   |   IPO News   |   Listed IPO Information   |   Hot Listed IPO
Stock Code   IPO News IPO Timetable
IPO Detail
02361 中康控股
Listing Date2022/07/12
Listing Price5.360
  • 4.470 0.000 (0.000%)    Sink Below Listing Price
  • 15-min delayed, last update: 24/03/2023 18:00
Subscription Result
  • Subscription Rate
  • Guarantee One Lot Size
    3 lot
  • One Lot Success Rate

Sinohealth Holdings primarily provides healthcare insight solutions to address the sales and marketing needs of medical product manufacturer clients. These solutions are based mainly on retail data. Its partnering pharmacies are important business partners who primarily supply it with retail data, forming a key component of database.

According to the iResearch Report, the Group ranked first for the medical products and channels segment of healthcare insight solutions in the PRC in terms of (i) revenue in 2021, and (ii) number of top medical product manufacturers and number of corporate clients served in 2020.

Its business model is supported by three core pillars, namely, (i) Sinohealth Engine which is a technology and data platform; ; (ii) Healthcare Industry Participant Networks and (iii) Big Data & AI Lab.

The Group have developed a broad client base covering key stakeholders in the healthcare industry chain, including medical product manufacturers, pharmacies, physical examination institutions, investment institutions, regulators, medical service institutions and insurance companies.

MarketHong Kong (Main Board)
Business NatureHealth Care
Major Business AreaChina
Board Lot500
No. of Offer Shares75.00M shares
No. of International Offer Shares67.50M shares
No. of HK Offer Shares7.50M shares
Offer Price$5.36 - $6.96
Stock Code2361
Sponsor(s)BNP Paribas Securities (Asia) Limited
Underwriter(s)BNP Paribas Securities (Asia) Limited, CCB International Capital Limited, Orient Securities (Hong Kong) Limited, Haitong International Securities Company Limited, UOB Kay Hian (Hong Kong) Limited, Guotai Junan Securities (Hong Kong) Limited, Eddid Securities and Futures Limited, Zhongtai International Securities Limited, Futu Securities International (Hong Kong) Limited, Innovax Securities Limited, Fosun Hani Securities Limited, Livermore Holdings Limited
Application PeriodJun 28 (Tue) - noon, Jul 05 (Tue)
Price Determination DateJul 05 (Tue)
Result Announcement DateOn or before Jul 11 (Mon)
Result Announcement DateOn or before Jul 11 (Mon)
Dealings in Shares commence onJul 12, 2022. (Tue)
Reallocation of Shares Offered
Times of HK Offer Shares Subscription15X - 50X50X - 100XOver 100X
% of total shares reallocated to HK Offer30%40%50%
Sales Statistics (HKD)
Offer Price$5.36 - $6.96
Capitalization2.41B - 3.13B
NAV / share ($)$1.87 - $2.14 (Unaudited pro forma adj NAV / share)
Use Of Proceeds
Assuming the offer price being at HKD 6.16, the net proceeds raised would be HKD 395.40M, of which
50.8% : Upgrade and enhance SaaS products with a focus on Smart Decision Cloud, Smart Retail Cloud and Smart Medical Cloud, and their marketing and promotion
49.2% : Conduct further research and development of technology and data warehouse, and in particular for AI technologies and the middleware for Sinohealth Engine
Related Document
Remark: The above information is referenced from the prospectus.
  All data is calculated from the non- exercise rights(if applicable).
IPO Calculator
Subscription --
Result Announcement --
Listing --
Offer Price︰--
Currency :
Listing Price :
Board Lot :
Admission Fee*
Subscribing Lot :
Subscribing Fee :

Subscribing Amount :
*Admission fees include brokerage of 1%, SFC transaction levy of 0.0027%, Stock Exchange trading fee of 0.005% and FRC transaction levy of 0.00015% (i.e. 1.0077% in total).
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2023 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.